WallStreetZenWallStreetZen

NASDAQ: KRTX
Karuna Therapeutics Inc Earnings & Revenue

KRTX past revenue growth

How has KRTX's revenue growth performed historically?
Company
-93.85%
Industry
182.01%
Market
17.81%
KRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

KRTX earnings and revenue history

Current Revenue
$654.0k
Current Earnings
-$433.7M
Current Profit Margin
-66,311.9%

KRTX Return on Equity

Current Company
-31.6%
Current Industry
-70.5%
Current Market
188%
KRTX's Return on Equity (-31.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KRTX announces earnings.

KRTX Return on Assets

Current Company
-30.4%
Current Industry
14.5%
KRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KRTX Return on Capital Employed

Current Company
-34.15%
Current Industry
36.3%
KRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KRTX$654.00k-$431.31M-$433.68M-86.70%N/A
LEGNN/AN/AN/AN/AN/A
SRPT$1.10B-$604.01M-$690.88M+32.18%N/A
TECH$1.14B$372.91M$224.16M+10.93%+17.11%
INCY$3.70B$919.43M$597.60M+14.45%+38.71%

Karuna Therapeutics Earnings & Revenue FAQ

What were KRTX's earnings last quarter?

On Invalid Date, Karuna Therapeutics (NASDAQ: KRTX) reported Q4 2023 earnings per share (EPS) of -$3.01, up 35.59% year over year. Total Karuna Therapeutics earnings for the quarter were -$113.82 million. In the same quarter last year, Karuna Therapeutics's earnings per share (EPS) was -$2.22.

If you're new to stock investing, here's how to buy Karuna Therapeutics stock.

What was KRTX's earnings growth in the past year?

As of Q1 2024, Karuna Therapeutics's earnings has grown year over year. Karuna Therapeutics's earnings in the past year totalled -$433.68 million.

What was KRTX's revenue last quarter?

On Invalid Date, Karuna Therapeutics (NASDAQ: KRTX) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Karuna Therapeutics's revenue was $5.28 million.

What was KRTX's revenue growth in the past year?

As of Q1 2024, Karuna Therapeutics's revenue has grown -93.85% year over year. This is 275.86 percentage points lower than the US Biotechnology industry revenue growth rate of 182.01%. Karuna Therapeutics's revenue in the past year totalled $654.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.